Navigation Links
REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body
Date:2/4/2008

Marked Improvement in Four Regions of Body Consistent with Overall PASI

Response in REMICADE-Treated Patients

SAN ANTONIO, Feb. 4 /PRNewswire/ -- Data from an integrated analysis of three randomized, placebo-controlled trials showed patients with moderate to severe plaque psoriasis receiving REMICADE(R) (infliximab) achieved a consistently high level of skin clearance in each of the four body regions (head, trunk, lower and upper extremities) as measured by the Psoriasis Area Severity Index (PASI). At week 10 of the analysis, which included nearly 1,500 subjects, 71 percent of patients receiving REMICADE 3 mg/kg and 79 percent of patients receiving REMICADE 5 mg/kg achieved a PASI 75, or at least a 75 percent improvement in the chronic inflammatory condition, compared with three percent of patients receiving placebo (both P < 0.001). Additionally, 39 percent and 52 percent of patients receiving REMICADE 3 mg/kg and 5 mg/kg, respectively, achieved a PASI 90, or nearly complete skin clearance, versus one percent of patients receiving placebo (both P < 0.001). Investigators reported these findings at the 66th Annual Meeting of the American Academy of Dermatology.

In September 2006, the U.S. Food and Drug Administration (FDA) approved REMICADE (5 mg/kg) for the treatment of chronic severe plaque psoriasis. Following an initial three infusion treatments (induction regimen), REMICADE is given once every eight weeks, or as few as six times a year.

"This analysis shows that treatment with REMICADE resulted in a consistently high level of clinical response in each quadrant of the body evaluated by PASI, and the results were consistent with patients' overall psoriasis improvement," said Alan Menter, MD, dermatologist, Baylor Research Institute, Dallas, and lead study investigator. "REMICADE remains an important advancement and biologic treatment option for a broad spectrum of patients with severe psoriasis."

According to f
'/>"/>

SOURCE Centocor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Observational Data Show Transfusion Patterns in Chemotherapy-Induced Anemia Patients Receiving Erythropoiesis-Stimulating Agents
2. TargeGen Announces Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients
3. JAK2 Inhibitor Shows Potent Activity in Cells From MPD Patients
4. Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors
5. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
6. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
7. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
8. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
9. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
10. Zevalin(R) Combined With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (ASCT) Produces High Overall Survival and Progression-Free Survival Rates in Patients With Relapsed Non-Hodgkins Lymphoma
11. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... The Intellectual Property and ... world,s leading provider of intelligent information for ... Clinical Trials Intelligence , its global clinical-drug-trial ... the documentation of more than 180,000 clinical ... and quicker access to critical data and ...
(Date:7/22/2014)... , July 22, 2014  ConvaTec, a privately-held medical ... Clerkin has been appointed chief financial officer of ... Clerkin was previously executive vice president and chief financial ... -based biotechnology company.  Mr. Clerkin was part of a ... Elan, culminating in its sale to Perrigo, a pharmaceutical ...
(Date:7/22/2014)... -- BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: ... appointed Charles J. (Chuck) Bramlage and Dr. ... Board.  Mr. Bramlage is a veteran ... and other commercial functions.  He is currently the Chief ... company that was recently acquired by AstraZeneca and is ...
Breaking Medicine Technology:Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 2Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 3ConvaTec Names Nigel Clerkin Chief Financial Officer 2BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 2BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 3BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 4BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 5BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 6BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 7
... (NASDAQ: GPRO ) announced today that the Company ... Growth Stock Conference in Chicago on June 15, 2011 at ... presentation is scheduled to be webcast live and may be ... website at www.gen-probe.com . The webcast will be available ...
... Educating the critical players in the pharmaceutical marketplace ... been considered a key component of a successful product ... diminished, education efforts have taken on new importance among ... Facing a competitive environment, organizations with new products are ...
Cached Medicine Technology:Gen-Probe to Webcast Presentation at the William Blair & Company 31st Annual Growth Stock Conference 2Educating Key Stakeholders to Support a Successful Pharmaceutical Product Launch 2
(Date:7/23/2014)... Residents of The Clare can now enjoy the abundance of ... on the fabulous cuisine of Chef Hagop Hagopian. “Residents love ... beach or museum and we love to make sure that ... Hughes, director of dining services for The Clare. “We offer ... the executive chef of The Clare is trained in French ...
(Date:7/22/2014)... Men and women who are fighting off the ... disposable income each year on different retail products. The ... aging products guide to help introduce natural products at ... released and accessible from any tablet, PC or smartphone ... and inserted into the guide to help make Internet ...
(Date:7/22/2014)... July 23, 2014 Recently, iFitDress.com, a popular ... has announced its new selection of white party dresses ... that custom made outfits are now available on its website. ... before the end of July can get a discounted rate, ... products are popular among international customers, so its marketing specialist ...
(Date:7/22/2014)... Marietta, Georgia and surrounding areas have more ... an efforts to lower population of needy pets; Marietta Vet ... Neuter Project have joined forces. Local businesses are being ... will be presented to the Tigg Neuter Project. , The ... are excited to attend and host the event. Local ...
(Date:7/22/2014)... July 22, 2014 Obtaining a bachelor’s ... military veterans who have hands-on medical experience. The School ... Greensboro today announced the launch of an accelerated nursing ... , The new program, the UNCG Veterans Access Program ... approximately 24 veterans. With some prior college credit, veterans ...
Breaking Medicine News(10 mins):Health News:Chicago’s The Clare Retirement Community Announces New Summertime Culinary Programs 2Health News:Best Anti Aging Products Guide Launched for Natural Product Buyers Online at News Portal 2Health News:Elegant White Party Dresses Now Provided by Distinguished Company iFitDress.com 2Health News:Marietta Vet Clinic Hosts 2014 Dog Days of Summer Pet Rescue Event 2Health News:UNCG School of Nursing Fast-Tracks Medically Trained Veterans 2
... number of youngsters trying to find their love live on the ... or BBS. // ,Li Mei met her boyfriend Liu Wei ... well-known Shuimu Tsinghua BBS (SMTH), which is run by students from ... engaged. ,"BBS is a bridge for our romance," said ...
... the survival rates has been documented in Acute Coronary ... analysis reported at the Society for Cardiovascular Angiography and ... May 10–13. ,By combining data from nine ... than in combination, the analysis was able to put ...
... nanomolcecules called ‘nanolipoblockers’ that guard against bad cholesterol. ... that they offer a local therapeutic effect,// aimed ... in cardiac patients. These nanoengineered molecules, which represent ... could soon join the fight against heart disease, ...
... A survey by the British Dental Health Foundation has found ... comes into their hand to clean off food debris// struck ... and knives are in common use, the survey said. ... food stuck in between their teeth giving rise to oral ...
... Commission will soon come up with recommendations to overhaul ... make it more competitive//, and to accommodate more students, ... come up with recommendations on the undergraduate educational set-up ... adding that a group has also been appointed to ...
... give drugs to end the life of those who are ... parliament//. The assisted dying bill of Britain was based on ... lethal drugs to patients who are suffering unbearably and have ... administered by the patients to themselves. But after a seven-hour ...
Cached Medicine News:Health News:Web Romance Is Catching Up Among The Youths In China 2Health News:Statin Therapy in Patients with Acute Coronary Syndrome Improves Survival 2Health News:Nanotechnology Could Revolutionize Cardiac Treatment 2Health News:Nanotechnology Could Revolutionize Cardiac Treatment 3
Velcro closures on each side to more evenly distribute the weight. Available in teal, royal, red, purple, or maroon nylon stain-resistant fabric or navy nylon reinforced vinyl....
Our quick release buckle apron is user friendly and our large support straps criss-crossing the back allows proper placement of the belt at your waist. Built-in shoulder pads add to the comfort....
An economical solution to the need to provide wrap-around protection. The one-sided velcro closure allows greater flexibility in sizing. Front protection is 0.5mm Pb and the back is 0.25mm Pb equival...
The most comfortable and easy to use apron in the industry. This front protection apron comes with a fully adjustable snap-on 5" orthopedic belt to relieve weight off your shoulders. Velcro strap acr...
Medicine Products: